Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Pharma Industry / Biotech Industry News

WorldCare Clinical Implements MCC's Imaging Performance Metrics In Support Of Standardized Peformance For Imaging Trials

Main Category: Pharma Industry / Biotech Industry
Also Included In: Clinical Trials / Drug Trials
Article Date: 23 Jun 2009 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

45th DIA Annual Meeting -- Booth # 1501 -- WorldCare Clinical, LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology and medical device industries, announced that it is offering version 1.0 of the Metrics Champion Consortium (MCC) Imaging Performance Metrics to all sponsors' imaging trials beginning July 1, 2009, through its WorldPro™ technology solution.

"We are pleased to announce that WCC is implementing the MCC Imaging Performance Metrics," said Dr. Asli Memisoglu, director of biostatistics and data management at WCC. "Through our innovative WorldPro technology platform, WCC is committed to support industry-wide acceptance of MCC's performance metrics to help ensure best outcomes for our sponsors."

The MCC Imaging Performance Metrics Work Group is a non-profit organization made up of biotechnology, pharmaceutical and service provider organizations that work collaboratively to develop and implement standardized performance metrics aimed at improving the efficiency and effectiveness of managing and tracking resources needed to successfully run clinical trials.

Additionally, WCC will offer statistical analysis of reader reliability, with metrics such as kappa and correlation coefficients, to evaluate reader performance and reliability. "It is critical for a study's success to have a high level of agreement across readers and good consistency within assessments made by the same reader," said Dr. Richard Walovitch, chief medical officer at WCC. "WCC provides the results from these ongoing evaluations to the client and the reading team in the form of a study newsletter, which helps to facilitate communication of case studies, reader performance, and operational metrics."

WCC representatives will be available at Booth # 1501 during this week's DIA Annual Meeting in San Diego, California, to discuss its application of the MCC and other metrics in imaging trials. For more information or to schedule an appointment, contact Vanessa Conde at (978) 406-5518 or vconde@wcclinical.com.

Source
WorldCare Clinical




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available For Relief Of Moderate To Severe Acute Pain
24 Jun 2009
Patients suffering from acute pain and healthcare professionals who treat pain have a new treatment option: NUCYNTA(TM) (tapentadol) CII immediate release tablets. This new medication for the relief of moderate to severe...


The Latest on LASIK
The Latest on LASIK

The latest technology gives doctors the ability to map the surface of a patient's eye. That unique map then guides the laser that reshapes the eye. But this technology comes at a price.

more videos are available in our health videos section.